Clinical Trials on HER2-low-expressing Breast Cancer in India
Total 139 results
-
Hoffmann-La RocheCompleted
-
Tata Memorial HospitalIndian Council of Medical ResearchUnknownTrial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients (CONSET)Breast Cancer | Pulmonary FibrosisIndia
-
Tata Memorial HospitalAll India Institute of Medical Sciences, New Delhi; Shri Siddhivinayak Ganpati... and other collaboratorsActive, not recruiting
-
Postgraduate Institute of Medical Education and...RecruitingBreast Cancer | Brain Metastases, Adult | Stereotactic Radiosurgery | Whole Brain RadiotherapyIndia
-
Hoffmann-La RocheCompleted
-
International Agency for Research on CancerMalabar Cancer Care Society Kannur, India; Bhabha Atomic Research Centre (BARC)...RecruitingCarcinoma in Situ | Breast CancerIndia
-
Novartis PharmaceuticalsRecruiting
-
POC Medical Systems, Inc.Unknown
-
Sun Pharma Advanced Research Company LimitedWithdrawnMetastatic Breast Cancer | Locally Recurrent CancerIndia
-
Hoffmann-La RocheCompleted
-
Sun Pharma Advanced Research Company LimitedTerminated
-
Tata Memorial HospitalActive, not recruitingBreast Cancer | Oral CancerIndia
-
SandozCompleted
-
Incyte CorporationTerminated
-
Sun Pharma Advanced Research Company LimitedCompletedRecurrent or Metastatic Breast CancerIndia
-
Institute of Cancer Research, United KingdomKortuc, Inc.RecruitingBreast CancerUnited Kingdom, India
-
Lupin Ltd.Completed
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
International Agency for Research on CancerGBH Cancer Memorial Hospital Udaipur, IndiaCompletedCervical Cancer | Breast Cancer | Oral Cancer | Cardio-vascular Disease | Stroke CancerIndia
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Eli Lilly and CompanyCompletedBreast CancerChina, India, Turkey, Korea, Republic of, Brazil, Mexico
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
OBI Pharma, IncCompletedMetastatic Breast CancerUnited States, Taiwan, Korea, Republic of, China, India
-
International Breast Cancer Research FoundationBreast Cancer Research FoundationCompletedBreast CancerUnited States, China, Bangladesh, Nigeria, Philippines, Morocco, India, Indonesia, Malaysia, Vietnam
-
U-Systems, Inc.Completed
-
PfizerCompletedBreast CancerAustralia, India
-
AstraZenecaCompletedBreast Cancer | Ovarian CancerIndia
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, Germany, Korea, Republic of, Brazil, Poland, Russian Federation, Turkey, Spain, Australia, France, Canada, United Kingdom
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Bharath Charitable Cancer Hospital and InstituteBangalore Institute of Oncology; CENTRAL COUNCIL FOR RESEARCH IN YOGA AND NATUROPATHYCompletedBreast Cancer | Chemotherapy-induced Nausea and Vomiting | Malignant Female Reproductive System Neoplasm | LymphomasIndia
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
NICHD Global Network for Women's and Children's...RecruitingPregnancy Outcome Trends in Low-resource Geographic AreasUnited States, Pakistan, Zambia, Congo, The Democratic Republic of the, Guatemala, India, Bangladesh
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Poland, Portugal, United Kingdom, France, Canada, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Brazil, Colombia, Greece, Taiwan, Malaysia, Philippines, Austria, R... and more
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
-
EirGenix, Inc.CompletedBreast CancerTaiwan, India, Georgia, United States, Russian Federation, South Africa, Ukraine, Belarus, Chile, Colombia, Korea, Republic of
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, India, Korea, Republic of, Taiwan, Spain, Germany, Austria, Italy, Peru, Russian Federation, Singapore, France, United Kingdom, Philippines, Argentina
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
Eli Lilly and CompanyActive, not recruitingBreast CancerChina, India, South Africa, Brazil
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, United Kingdom, Kenya, Turkey, Hungary, Colombia, India, Oman, Saudi Arabia, Poland, Uganda, United... and more
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more
-
AstraZenecaCompletedBreast CancerThailand, Korea, Republic of, Japan, Philippines, Taiwan, India